• TITLE: Comparison of intracameral injection with subconjunctival injection of dexamethasone for postoperative inflammation in congenital cataracts
Introduction: Cataract affects a huge population around the globe and equally affects Pakistani population. Children with congenital cataract presents with huge deformity and dependence, the consequences are lifelong if not treated with better management at right time. In this study we aimed at comparing intracameral and subcojunctival injection of dexamethasone in congenital cataract in terms of postoperative inflammation.
Purpose: The purpose of our study is comparing the role of intracameral injection with subconjunctival injection of dexamethasone in preventing immediate postoperative inflammation after congenital cataract extraction and to make the ground for better option for programmatic implementation in these cases.
Study Design: Randomized control trial
Place and duration of study: Holy Family Hospital, Rawalpindi since june 2014 to May 2015.
Material and methods: In this RCT, 190 children with congenital cataract were enrolled in the department of ophthalmology, Holy Family Hospital, Rawalpindi. Patients were selected using a random table, 95 cases each in intracameral injection and subconjunctival injection of dexamethasone groups.The study duration was one year from june 2014 to May 2015. Ethical approval was granted by hospital ethics committee and patients were administered a written informed consent at enrolment. The outcome measure was intraocular inflammation after surgery for extraction of cataract.
Results: Male cases were in majority in group B (58.9%) whereas in group A females (55.8%) were in majority. Mean age was6.43 ± 4.69 years in Group-A compared to 5.85 ± 4.10 years in Group-B. Frequency of posterior synechiae (inflammation) was 4.21% (n=4) in Group-A (intracameral) compared to 15.79% (n=15) in Group-B (subconjunctival) which was significantly different (p-value, 0.007).
Conclusion: Intracameral injection is better than subjunctival injection of dexamethasone in the management of post-operative inflammation in children with congenital cataract.
1. Rao GN, Khanna R, Payal A. The global burden of cataract. CurrOpin Ophthalmol. 2011;22:4-9.
2. Jadoon Z, Shah SP, Bourne R, Dineen B, Khan MA, Gilbert CE. Cataract prevalence, cataract surgical coverage and barriers to uptake of cataract surgical services in Pakistan: the Pakistan National Blindness and Visual Impairment Survey.
Br J Ophthalmol.2007; 91:1269-73.
3. S Sheeladevi, J G Lawrenson, A R Fielder, C M Suttle.Global prevalence of childhood cataract: a systematic review.
Eye (Lond). 2016 Sep;30: 1160–69
4. Courtright P, Hutchinson AK, Lewallen S. Visual impairment in children in middle- and lower-income countries. Arch Dis Child 2011;96:1129-34.
5. Hoffman RS, Braga-Mele R, Donaldson K, et al. Cataract surgery and nonsteroidalantiinflammatory drugs. J Cat Refract Surg 2016;42:1368-1379.
6. Chan WH, Biswas S, Ashworth JL, Lloyd IC. Educational paper: Congenital and infantile cataract: etiology and management. Eur J Pediatr 2012;171:625-30.
7. Kuhli HC, Lüchtenberg M, Kohnen T, Hattenbach LO. Risk factors for complications after congenital cataract surgery without intraocular lens implantation in the first 18 months of life. Am J Ophthalmol 2008;146:1-7.
8. Huang Y, Dai Y, Wu X, Lan J, Xie L. Toxic anterior segment syndrome after pediatric cataract surgery. J Am Acad Ped Ophthalmol Strabismus 2010;14:444-6.
9. Chang DT, Herceg MC, Bilonick RA, Camejo L, Schuman JS, Noecker RJ. Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma. Clin Ophthalmol 2009;3:345-55.
10. Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW. Single perioperative subconjunctival steroid depot versus postoperative steroid eye drops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg 2011;37:1589-97.
11. Halilbasic M, Zvornicanin J, Jusufovic V, et all. Pediatric cataract in Tuzla Canton, Bosnia and Herzegovina. Med Glas (Zenica) 2014; 11:127-31.
12. Santhiya ST, Kumar GS, Sudhakar P, Gupta N, Klopp N, Illig T, etc. Molecular analysis of cataract families in India: new mutations in the CRYBB2 and GJA3 genes and rare polymorphisms.Mol Vis. 2010;16:1837-47
13. Randrianotahina HC, Nkumbe HE. Pediatric cataract surgery in Madagascar. Niger J ClinPract. 2014;17:14-7.
14. Nkumbe HE, Randrianotahina HC. Meeting the need for childhood cataract surgical services in Madagascar. Afr J Paediatr Surg. 2011; 8:182-4.
15. Bronsard A, Geneau R, Shirima S, Courtright P, Mwende J. Why are children brought late for cataract surgery? Qualitative findings from Tanzania. Ophthalmic Epidemiol 2008; 15:383-8.
16. World Health Organisation. Prevention of childhood blindness. Geneva: WHO; 1992
17. Sana N, Muhammad A, HumairaF.Congenital Cataract: Morphology and Management Pak J Ophthalmol.2013; 29:151-55.
18. Aptel F, Colin C, Kaderli S, Deloche C, Bron AM, Stewart MW, Chiquet C; OSIRIS group. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol 2017; 101: 1-10.
19. Iqbal CJ, Ali Z, Ahmad KA, Akram MA. Comparison of intracameral dexamethasone and subconjunctival dexamethasone in reducing postoperative inflammation after cataract surgery. Ophthalmol Pak 2011; 1:8-11
20. Ahmad CN, Khan AA, Siddique Z, Ahmed S. Role of Intracameral Dexamethasone in Preventing Immediate Postoperative Anterior Uveitis in Paediatric Cataract Extraction. Pak J Med Health Sci 2010;4;338-42
21. Jamil AZ, Ahmed A, Mirza KA. Effect of Intracameral Use of Dexamethasone on Corneal Endothelial Cells. J CollPhysSurg Pak 2014; 24: 245-8.
22. Zhang G, Liu S, Yang L, Li Y. The role of Dexamethasone in clinical pharmaceutical treatment for patients with cataract surgery.Experiment Therap Med 2018; 15: 2177-2181